Mitoxantrone, Etoposide, and Cytarabine (MEC) Following Epigenetic Priming with Decitabine in Adults with Relapsed/Refractory Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS): A Phase 1 Study
暂无分享,去创建一个
E. Estey | D. Stirewalt | M. Othus | R. Walter | M. Shadman | P. Becker | P. Hendrie | B. Scott | F. Ostronoff | A. Halpern | Morgan A. Powell | Tara L. Chen | K. F. Orlowski | Elizabeth M. Ranker